BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 24335555)

  • 1. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
    Theriot CM; Young VB
    Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.
    Theriot CM; Young VB
    Annu Rev Microbiol; 2015; 69():445-61. PubMed ID: 26488281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.
    Theriot CM; Koenigsknecht MJ; Carlson PE; Hatton GE; Nelson AM; Li B; Huffnagle GB; Z Li J; Young VB
    Nat Commun; 2014; 5():3114. PubMed ID: 24445449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifts in the Gut Metabolome and
    Fletcher JR; Erwin S; Lanzas C; Theriot CM
    mSphere; 2018; 3(2):. PubMed ID: 29600278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.
    Thanissery R; Winston JA; Theriot CM
    Anaerobe; 2017 Jun; 45():86-100. PubMed ID: 28279860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
    Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
    mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 10. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.
    Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB
    Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.
    Ferreyra JA; Wu KJ; Hryckowian AJ; Bouley DM; Weimer BC; Sonnenburg JL
    Cell Host Microbe; 2014 Dec; 16(6):770-7. PubMed ID: 25498344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
    Britton RA; Young VB
    Gastroenterology; 2014 May; 146(6):1547-53. PubMed ID: 24503131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
    Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.
    Britton RA; Young VB
    Trends Microbiol; 2012 Jul; 20(7):313-9. PubMed ID: 22595318
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Jenior ML; Leslie JL; Young VB; Schloss PD
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.
    Leslie JL; Vendrov KC; Jenior ML; Young VB
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30700514
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.
    Theriot CM; Bowman AA; Young VB
    mSphere; 2016; 1(1):. PubMed ID: 27239562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
    Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
    Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
    Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
    PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.